Chronicles of A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists (MSDC was founded on October 4, 1891). Bulletin of the MSDC № 1150
{"title":"Chronicles of A.I. Pospelov Moscow Society of Dermatovenerologists and Cosmetologists (MSDC was founded on October 4, 1891). Bulletin of the MSDC № 1150","authors":"Alexey B. Yakovlev, Ivan S. Maximov","doi":"10.17816/dv139219","DOIUrl":null,"url":null,"abstract":"On December 20, 2022, the 1150th meeting of the Moscow Society of Dermatovenerologists and Cosmetologists (MSDC) named after A.I. Pospelov took place.
 The meeting was held in a face-to-face format. There were 110 participants in total. Accepted as a member of the MSDC 3 people.
 Two clinical cases are presented in the clinical part of the meeting: widespread cutaneous leishmaniasis in an HIV-infected patient. The peculiarity of this clinical case was the extreme prevalence of rashes. No systemic pathology was detected; panniculitis in a patient after a COVID-19 infection. The process proceeded according to the type of non-stagnant Weber-Christian panniculitis: after surgical autopsy, a mucus-like substance was released.
 Three reports were presented in the scientific part of the meeting. Corresponding member Prof. O.Y. Olisova (Sechenov University) made a report on the benefits of treating severe and moderate psoriasis with netakimab; researcher of State Scientific Center of Dermatovenereology and Cosmetology Central Dermatology and Venereology Institute A.A. Vorontsova reported on the results of an original study of the generality of clinical and pathomorphological manifestations of psoriasis and T-cell lymphoma; with pathogenetic justification of the development of cutaneous toxicity as a result of targeted therapy of oncological diseases was performed by E.V. Orlova (Sechenov University): it is based on the suppression and dysfunction of EGFR-controlled processes in the skin.","PeriodicalId":487039,"journal":{"name":"Rossiiskii Zhurnal Kozhnykh i Venericheskikh Boleznei","volume":"210 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rossiiskii Zhurnal Kozhnykh i Venericheskikh Boleznei","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/dv139219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
On December 20, 2022, the 1150th meeting of the Moscow Society of Dermatovenerologists and Cosmetologists (MSDC) named after A.I. Pospelov took place.
The meeting was held in a face-to-face format. There were 110 participants in total. Accepted as a member of the MSDC 3 people.
Two clinical cases are presented in the clinical part of the meeting: widespread cutaneous leishmaniasis in an HIV-infected patient. The peculiarity of this clinical case was the extreme prevalence of rashes. No systemic pathology was detected; panniculitis in a patient after a COVID-19 infection. The process proceeded according to the type of non-stagnant Weber-Christian panniculitis: after surgical autopsy, a mucus-like substance was released.
Three reports were presented in the scientific part of the meeting. Corresponding member Prof. O.Y. Olisova (Sechenov University) made a report on the benefits of treating severe and moderate psoriasis with netakimab; researcher of State Scientific Center of Dermatovenereology and Cosmetology Central Dermatology and Venereology Institute A.A. Vorontsova reported on the results of an original study of the generality of clinical and pathomorphological manifestations of psoriasis and T-cell lymphoma; with pathogenetic justification of the development of cutaneous toxicity as a result of targeted therapy of oncological diseases was performed by E.V. Orlova (Sechenov University): it is based on the suppression and dysfunction of EGFR-controlled processes in the skin.